Posted By Kieran Beauchamp On 15 Dec 2025 Comments (10)
Market exclusivity extensions let pharmaceutical companies delay generic competition for years beyond patent expiration using FDA-granted protections like orphan drug status and pediatric extensions. Here's how they work-and why they're costing patients billions.
READ MORE
Posted By Kieran Beauchamp On 12 Dec 2025 Comments (8)
The FDA's Orange Book database lists approved drugs, their patents, and therapeutic equivalence ratings - helping pharmacists, generic manufacturers, and patients know when cheaper alternatives are legally available.
READ MORE